OptimizeRx Co. (NASDAQ:OPRX) Receives $15.86 Average Price Target from Analysts
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six research firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price target among […]
More Stories
Cerity Partners LLC Purchases 249,475 Shares of Bristol-Myers Squibb (NYSE:BMY)
Cerity Partners LLC increased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 38.9% in the third...
Stryker Co. (NYSE:SYK) Shares Bought by Larson Financial Group LLC
Larson Financial Group LLC grew its holdings in Stryker Co. (NYSE:SYK – Free Report) by 3.4% in the 3rd quarter,...
Larson Financial Group LLC Has $5.87 Million Holdings in Fidelity Total Bond ETF (NYSEARCA:FBND)
Larson Financial Group LLC boosted its position in Fidelity Total Bond ETF (NYSEARCA:FBND – Free Report) by 1,376.5% during the...
SPDR Gold MiniShares Trust (NYSEARCA:GLDM) Shares Purchased by Managed Asset Portfolios LLC
Managed Asset Portfolios LLC raised its stake in SPDR Gold MiniShares Trust (NYSEARCA:GLDM – Free Report) by 0.5% in the...
Centaurus Financial Inc. Sells 2,808 Shares of iShares Global 100 ETF (NYSEARCA:IOO)
Centaurus Financial Inc. trimmed its holdings in iShares Global 100 ETF (NYSEARCA:IOO – Free Report) by 2.4% in the 3rd...
Centaurus Financial Inc. Buys 59,729 Shares of SoFi Enhanced Yield ETF (NYSEARCA:THTA)
Centaurus Financial Inc. lifted its stake in shares of SoFi Enhanced Yield ETF (NYSEARCA:THTA – Free Report) by 16.9% during...